Riddle Appointed to Texas Board of Nursing

Translate to Spanish or other 102 languages!

Governor Greg Abbott has appointed Dru Riddle Ph.D., DNP, CRNA, FAAN to the Texas Board of Nursing for a term set to expire on January 31, 2029, effective September 1, 2023. Image Source: Riddle Facebook for illustration purposes
Governor Greg Abbott has appointed Dru Riddle Ph.D., DNP, CRNA, FAAN to the Texas Board of Nursing for a term set to expire on January 31, 2029, effective September 1, 2023. Image Source: Riddle Facebook for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN, Texas – Governor Greg Abbott has appointed Dru Riddle Ph.D., DNP, CRNA, FAAN to the Texas Board of Nursing for a term set to expire on January 31, 2029, effective September 1, 2023. The Board oversees the practice of professional nursing, examination of students, and standards of professional conduct for license holders. The Board also prescribes and publishes the minimum requirements and standards for course studies in various nursing degree programs.

Dru Riddle, Ph.D., DNP, CRNA, FAAN of Fort Worth is an associate professor at Texas Christian University and teaches nurse anesthesia. He is also a clinically practicing nurse anesthetist in the Fort Worth community. He is the president of the American Association of Nurse Anesthesiology and a member the Texas Association of Nurse Anesthetists, American Academy of Nursing, American Nurses Association, and the Texas Nurses Association. Additionally, he serves as a member of the Texas Board of Nursing APN Advisory Committee. He is a former member of the Southern Nurses Research Society. Riddle received a Bachelor of Science in Nursing from Virginia Commonwealth University, a Master of Science in Nurse Anesthesia from Old Dominion University, a Doctor of Nursing Practice from Texas Christian University, and a Doctor of Philosophy in Nursing and Genetics from The Medical University of South Carolina.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.
- Advertisement -